Scott C. Meixner
YOU?
Author Swipe
View article: Correction of haemorrhagic shock-associated coagulopathy and impaired haemostasis by plasma, prothrombin complex concentrates or an activated protein C-targeted DNA aptamer in mice
Correction of haemorrhagic shock-associated coagulopathy and impaired haemostasis by plasma, prothrombin complex concentrates or an activated protein C-targeted DNA aptamer in mice Open
View article: CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models
CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models Open
View article: Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency
Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency Open
The activated form of coagulation factor XIII (FXIII-A2B2), FXIII-A*, is a hemostatic enzyme essential for inhibiting fibrinolysis by irreversibly crosslinking fibrin and antifibrinolytic proteins. Despite its importance, there are no modu…
View article: Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity
Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity Open
View article: Thrombolysis by chemically modified coagulation factor Xa
Thrombolysis by chemically modified coagulation factor Xa Open